<DOC>
	<DOCNO>NCT02846038</DOCNO>
	<brief_summary>Honest , clear , empathetic communication pediatric oncologist ( POs ) parent child cancer ( POCCs ) imperative facilitate therapeutic alliance ensure medical management aligns family ' goal care . Communication particularly important conversation disease reevaluation , often necessitate parental decision-making context emotional distress . POs employ spectrum communication style strategy challenge conversation , consensus regard linguistic thematic metric high quality communication upset information . In order well understand POs communicate difficult information POCCs , investigator propose pilot study design accomplish follow primary aim : Primary Objective : - To identify recurrent verbal nonverbal ( e.g . use pauses/silence ) communication technique employ POs delivery difficult prognostic information POCCs content analysis audio-recorded conversation POs parent child high risk cancer time disease reevaluation . The study expect enroll : 30 patient participant , 30 parent , 6 primary pediatric oncologist , 30 non-primary oncologist care team member , 30 extend family member , 30 friend family ( total = 156 ) .</brief_summary>
	<brief_title>Understanding Communication Healthcare Achieve Trust ( U-CHAT )</brief_title>
	<detailed_description>Data collection occur maximum 2 survey maximum 3 interview oncologist parent/patient . Disease reevaluation define follow intervention perform purpose assess disease status : - Diagnostic image - Lumbar puncture cerebrospinal fluid analysis - Bone marrow aspiration and/or biopsy - Surgical biopsy resection The first time point data collection time patient 's first meeting oncologist discus result disease reevaluation . This discussion audio-recorded . The parent ask complete survey within 7 day . Those receive difficult news opportunity participate brief interview study team member regard experience . Patients least 12 year old also opportunity , separate parent , desire patient approve parent . Interviews may person phone set length . The next time point data collection coincide time patient/parents meet oncologist discus result disease reevaluation . Each conversation audio-recorded . If difficult news deliver discussion , parent ( patient , desire ) ask complete survey . All data analyze audio-recordings permanently erase recorder follow completion data analysis . Participants may request discontinue study time .</detailed_description>
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Neoplasms , Germ Cell Embryonal</mesh_term>
	<mesh_term>Retinoblastoma</mesh_term>
	<mesh_term>Wilms Tumor</mesh_term>
	<mesh_term>Desmoplastic Small Round Cell Tumor</mesh_term>
	<mesh_term>Hepatoblastoma</mesh_term>
	<criteria>Inclusion Criteria Primary Oncologist : Primary oncologist attend physician ( age 18+ ) provide medical care patient outpatient Solid Tumor Clinic St. Jude Children 's Research Hospital . Primary hematologyoncology fellow ( age 18+ ) follow patient along primary oncologist eligible participate audiorecorded disease reevaluation conversation ( fellow contribution distinguish primary oncologist contribution ) ; however , eligible complete postconversation survey semistructured interview . Inclusion Criteria Parents Children Cancer : Caregiver 18 year age old . Caregiver relate patient one follow way : biological parent , stepparent , primary legal guardian . If 1 set parent involve , caregiver legal decisionmaking responsibility eligible participation . Caregiver comfortable speak read English . Inclusion Criteria Patients : Patient 's primary oncologist enrol study . Patient ( age ≤30 year ) diagnose one follow disease : highrisk neuroblastoma , sarcoma , carcinoma , desmoplastic small round cell tumor , incompletely resect metastatic retinoblastoma , Wilms tumor , germ cell tumor , hepatoblastoma , melanoma . Patient 's primary pediatric oncologist document report his/her impression patient 's likelihood cure 50 % less . Patient project ≥ 2 future time point disease reevaluation , document electronic medical record ( EMR ) and/or confirm patient 's primary oncologist . Patient treat one highrisk diseases &lt; 3 month endoftherapy disease evaluation , OR Patient 's disease relapse , progress , respond therapy , document EMR and/or confirm child 's pediatric oncologist . Inclusion Criteria NonPrimary Oncologist Care Team Members , Patient 's Extended Family Member , Friend Family : Patient 's primary oncologist enrol study . Patient 's caregiver enrol study . Patient 's caregiver give verbal permission nonprimary oncologist clinical member patient 's care team , extend family member , friend family present conversation patient 's primary oncologist patient 's caregiver . nonprimary oncologist member patient 's clinical care team , extend family member , friend family ( age 18+ year ) give verbal consent audiorecorded prior begin conversation , case speak conversation patient 's primary oncologist patient 's caregiver . Implicitly state inclusion criterion . Inability unwillingness ot potential research participant legal guardian/representative give inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Pediatric cancer</keyword>
	<keyword>Childhood cancer</keyword>
	<keyword>High-risk disease</keyword>
	<keyword>Prognosis</keyword>
	<keyword>Communication</keyword>
	<keyword>Bad news</keyword>
	<keyword>Pediatric oncologist</keyword>
	<keyword>Parent</keyword>
	<keyword>Relapse</keyword>
	<keyword>Progression</keyword>
</DOC>